Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7759]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
Emergence of ipilimumab and vemurafenib for melanoma
Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker
Emergence of ipilimumab and vemurafenib for melanoma ( Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker )
15 Jul 2011
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of...
Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre...
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life ( Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston )
14 Jul 2011
VTD consolidation therapy for multiple myeloma
Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli...
VTD consolidation therapy for multiple myeloma ( Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy )
14 Jul 2011
Dasatinib therapy for CML patients unsuitable for imatinib
Prof Giuseppe Saglio - University of Turin, Italy
Dasatinib therapy for CML patients unsuitable for imatinib ( Prof Giuseppe Saglio - University of Turin, Italy )
14 Jul 2011
Latest advances in multiple myeloma
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Latest advances in multiple myeloma ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
14 Jul 2011
Advances in CLL treatment
Prof Peter Hillmen - St James’s University Hospital, Leeds, UK
Advances in CLL treatment ( Prof Peter Hillmen - St James’s University Hospital, Leeds, UK )
14 Jul 2011
TKI treatment for chronic myeloid leukaemia
Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA
TKI treatment for chronic myeloid leukaemia ( Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA )
14 Jul 2011
Development of lenvatinib for thyroid cancer
Prof Steven Sherman - MD Anderson Cancer Center, Texas, USA
Development of lenvatinib for thyroid cancer ( Prof Steven Sherman - MD Anderson Cancer Center, Texas, USA )
28 Jun 2011
The changing landscape of melanoma therapies: indications of better patient...
Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof...
The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )
24 Jun 2011
Role of vemurafenib in melanoma treatment
Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK
Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )
24 Jun 2011
Research from the Sarah Cannon Research Institute
Dr Howard (Skip) Burris - The Sarah Cannon Research Institute, Nashville, USA
Research from the Sarah Cannon Research Institute ( Dr Howard (Skip) Burris - The Sarah Cannon Research Institute, Nashville, USA )
24 Jun 2011
Clinical research at Sarah Cannon UK
Dr Tobias Arkenau - The Sarah Cannon Research Institute, London, UK
Clinical research at Sarah Cannon UK ( Dr Tobias Arkenau - The Sarah Cannon Research Institute, London, UK )
24 Jun 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation